Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Masucci
Observed name:
C. Masucci
Institution:
Azienda Ospedaliera S.Giuseppe Moscati
Observed institutions:
Policlinico Umberto I,
Azienda Ospedaliera S.Giuseppe Moscati,
Ospedale Santa Maria Goretti,
Sapienza University of Rome
ORCID:
0000-0003-2374-3299
Observed ORCID:
0000-0003-2374-3299
OpenAlex ID:
A5079957655
Systemic mastocytosis: 2023 update on diagnosis and management in adults
2023
·
Alessandro Costa
, Emilia Scalzulli
, et al.
·
Expert Opinion on Emerging Drugs
·
14
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
2024
·
Danilo De Novellis
, Daniele Derudas
, et al.
·
European Journal Of Haematology
·
9
PDF
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS
2023
·
Chiara Masucci
, Sara Pepe
, et al.
·
Frontiers in Oncology
·
8
PDF
Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP : A single‐centre case series
2024
·
Mauro Passucci
, Alessandro Laganà
, et al.
·
British Journal of Haematology
·
7
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban: results from a patient population with more than 2 years of median follow-up
2024
·
Alessandro Laganà
, Giovanni Manfredi Assanto
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
6
PDF
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases
2023
·
Giovanni Iaquinta
, Emilia Scalzulli
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
5
Case Report: Infectious prophylaxis in hematological malignancies
2023
·
Mauro Passucci
, Chiara Masucci
, et al.
·
Frontiers in Oncology
·
5
PDF
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination
2023
·
Chiara Masucci
, Mauro Passucci
, et al.
·
Frontiers in Oncology
·
3
PDF
One‐month qRT‐PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission
2023
·
Alessandro Laganà
, Sara Pepe
, et al.
·
European Journal Of Haematology
·
2
PDF
Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report
2022
·
Martina Di Palma
, Elio Gentilini
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
2
PDF
Long Term Survival in Multiple Myeloma Patients: A Multicenter Italian Experience
2022
·
Francesca Fazio
, Martina Gherardini
, et al.
·
Blood
·
1
Luspatercept in Myelodysplastic Syndromes With Ring Sideroblasts: Long Term Outcome and Impact on Non‐Erythroid Blood Counts
2026
·
Mara Memoli
, Stefania Leone
, et al.
·
Hematological Oncology
PDF
An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies
2025
·
Danilo De Novellis
, Salvatore Palmieri
, et al.
·
Annals of Hematology
PDF
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort
2023
·
Alessandro Costa
, Ida Carmosino
, et al.
·
European Journal Of Haematology
PDF
Show more works
View as search
Works count:
18
Citation count:
62
H-index:
5
I10-index:
1
Year
Topic
Type